Feature | February 17, 2011| Dave Fornell

Cardiovascular Trends to Watch in 2011

Based on my observations and the devices that caught the eye of the doctors on the Diagnostic & Interventional Cardiology Editorial Advisory Board, we created the following predictions of what will be hot trends to watch in 2011. These were some of the big topics and new technologies highlighted at the Transcatheter Cardiovascular Therapeutics (TCT) symposium in September, and the American Heart Association (AHA) and the Radiological Society of North America (RSNA) meetings in November.

Percutaneous valves: These devices are now a reality in Europe and will be coming to the U.S. market shortly. The first results from the U.S. PARTNER trial presented at TCT for the Edwards Sapien aortic valve were very positive. In December, Medtronic began its first U.S. implants of the CoreValve aortic valve as part of the U.S. pivotal trial.

Robotics in the cath lab: The Davinci system has made a dramatic impact on urologic practice and Stereotaxis and Hansen are vying for the electrophysiology market. The first in-human study of the robotically assisted percutaneous coronary intervention system demonstrated that the technique is safe and feasible. The results of the study of the CorPath 200, by Corindus Vascular Robotics, were presented at TCT. The system allows interventional cardiologists to sit down without radiation protection and remotely manipulate catheters, wires, balloons and stents from the control booth.

Advanced cath lab imaging: The introduction of rotational angiography in the cath lab with a rapid rotation of the imaging arm creates dynamic CT-like 3-D imaging, which can be used as an overlay with routine angiographic imaging. The technology allows for real-time CT superimposition, allowing for more accurate endovascular work and might become a routine part of any endovascular suite. This type of technology might also be useful at defining physiology, such as ischemia. Other advances include improved hybrid overlay images from various imaging modalities and live angiography for better transcatheter navigation.

Percutaneous renal nerve ablation: This was discussed as a new treatment to reduce blood pressure. Data from Ardian’s Symplicity HTN-2 trial of its renal ablation catheter was presented at AHA. It showed after six months, patients treated with Ardian’s device experienced an average drop in blood pressure of 32/12 mmHg compared to an increase in blood pressure of 1/0 mmHg in the control group of patients treated with medical therapy alone.

Left atrial appendage (LAA) occlusion devices: These transcatheter occluders are designed to prevent atrial fibrillation-induced emboli and replace the current standard of warfarin therapy. The CoHerex WaveCrest has an improved design over previous devices that have been tested and is entering first-in-man trials in 2011.

iPad integration of picture archiving and communication systems (PACS): Healthcare software vendors are introducing a large variety of new apps for the iPad, including advanced visualization software and access to PACS and cardiac reporting software. The iPad frees clinicians from their desktop computer and allows them to work from any location with Internet access. The small size of the device means it can be carried around like the traditional clipboard, but offers all the functionality of their primary computer workstation.

PET/MRI: The first two combined positron emission tomography/magnetic resonance imaging (PET/MRI) systems were introduced at RSNA by Philips and Siemens. These systems have the potential to greatly reduce radiation dose by eliminating CT scans in hybrid imaging, which have been used for attenuation correction and for an anatomical overlay to the PET metabolic imaging. Both systems are pending FDA clearance.

3-D hearts in motion: Advanced visualization can make pretty pictures of 3-D anatomy, but in the case of the heart, it has so far failed to show functionality and natural movement during the cardiac cycle. Using supercomputing algorithms, Ziosoft developed the PhyZiodynamic software to take a CT or MRI data set of a cardiac cycle and put it into motion. The software allows a full 3-D rendering of a heart in motion that can be sliced through and rotated on any axis. It also has an option to show a color-coded tissue strain map.

Related Content

Vital Images, Vitrea 7 advanced visualization software, SCCT 2016
Technology | Advanced Visualization| June 30, 2016
Vital Images Inc. recently launched version 7 of its Vitrea advanced visualization software. This application-based...
Sponsored Content | Videos | Structural Heart| June 30, 2016
Interview with Steven Little, M.D., medical director of the Valve Clinic at the Houston Methodist DeBakey Heart and V
HeartFlow, FFR-CT Analysis, next-generation platform, second FDA clearance
Technology | CT Angiography (CTA)| June 29, 2016
HeartFlow Inc. announced that it is launching its next generation of the HeartFlow FFR-CT Analysis. The result of years...
DEFUSE-2 study, MRI, brain bleeding risk, post-stroke treatment, NIH

This image combines pre- and post-treatment scans from the same patient. Analysis of the two scans revealed that the area and size of post-treatment bleeding corresponded to blood-brain barrier disruption (shown in green, yellow and red) prior to therapy. Image courtesy of Richard Leigh, NINDS.

News | Stroke| June 29, 2016
In a study of stroke patients, investigators confirmed through magnetic resonance imaging (MRI) brain scans an...
Sponsored Content | Videos | Cardiovascular Ultrasound| June 28, 2016
Interview with Rebecca Hahn, M.D., FASE, Columbia University Medical Center, New York, at the American Society of Ech
UAB, University of Alabama at Birmingham, Jianyi Jay Zhang, custom-engineered heart tissue
News | Stem Cell Therapies| June 28, 2016
June 24, 2016 — The University of Alabama at Birmingham (UAB) announced the launch of new research by Jianyi “Jay” Zh
BHF, Reflections of Research image competition, U.K., 4-D MRI, heart blood flow

This image shows blood flow within the main pumping chambers – the ventricles – on both sides of the heart and the vessels leaving the heart. The blue flow is blood that needs oxygen and is travelling to the lungs. The red flow is blood that has been through the lungs and received oxygen. Victoria Stoll of the University of Oxford is using this type of imaging to look at the blood flow within the hearts of people with heart failure, whose hearts are not pumping effectively.

News | Cardiac Imaging| June 24, 2016
The British Heart Foundation (BHF) announced the winners of its annual ‘Reflections of Research’ image competition,...
Biotronik, CardioStim 2016 Innovation Award, MRI AutoDetect, Ilivia ICDs
News | EP Lab| June 23, 2016
Biotronik announced it was the winner of the Cardiostim Innovation Award in the category “Best Practice Improvement”...
ACR Select, Appropriateness Criteria, federal AUC requirements, qPLEs
News | Clinical Decision Support| June 23, 2016
The Centers for Medicare & Medicaid Services (CMS) has named the American College of Radiology (ACR) a “qualified...
Overlay Init